Pharmaceutical Pricing and Healthcare Access

Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.

Related Content:

Regulatory WatchPharmaceutical Technology-03-02-2004

FDA Joins Effort to Curb Drug Patent Abuses

Gamesmanship Escalates over FDA User Fee Legislation

FDA Advances Quality Initiatives to Combat Drug Shortages